专利检索 ap:("ONO PHARMACEUTICAL CO., LTD.") AND inv:"Maki KONDO" 第 1 页

1.

发明公开
CANCER TREATMENT BY COMBINATION OF EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR 审中-公开

公开(公告)号：US20230390303A1

公开(公告)日：2023-12-07

申请号：US18035608

申请日：2021-11-12

申请人： ONO PHARMACEUTICAL CO., LTD.

发明人： Maki KONDO

IPC分类号： A61K31/555 , A61K31/337 , A61K31/513 , A61K31/7068 , A61K31/4745 , A61K31/519 , A61K31/506 , A61K31/353 , C07K16/28 , A61P35/00

CPC分类号： A61K31/555 , A61K31/337 , A61K31/513 , A61K31/7068 , A61P35/00 , A61K31/519 , A61K31/506 , A61K31/353 , C07K16/2827 , A61K31/4745

摘要： The object of the present invention is to provide an effective method for treating cancer. Provided is a method for treating cancer including a combination of a standard therapy, an EP4 antagonist and an immune checkpoint inhibitor (for example, an anti-PD-1 antibody). The therapeutic method of the present invention is useful for cancer treatment.